News for hackers. Stuff that matters.
Re:FDA agrees to expanded access program for MDMA-assisted p... by rincebrain on Wednesday February 19, 2020 @03:31PM (#22369737)
Many psychiatric medications exist, but since most of the things we group together as depression or generalized anxiety or others are some subset of a large number of possible causes, efficacy of these pills for any given person is rolling the dice, and takes O(months) to test a given med (for depression and bipolar meds, at least - O(weeks) per dose change).

Plenty of people can testify to the efficacy of some of these meds for them personally, but even within families, having an immediate family member who responded well to a given drug is no guarantee it'll work well on you (though it's still better odds than without that data).

Also, drugs+therapy leads to a better outcome, generally, than just drugs. So having more tools available, particularly a tool that improves the efficacy of therapy, is definitely a win.

Re:FDA agrees to expanded access program for MDMA-assisted p... by phkahler on Wednesday February 19, 2020 @04:28PM (#22370286)
This is different than other medications. You dont prescribe it. It's only used during therapy sessions. Long term use IIRC causes brain lesions or something like that.
Re:FDA agrees to expanded access program for MDMA-assisted p... by sibeliuss on Wednesday February 19, 2020 @04:37PM (#22370362)
> Long term use IIRC causes brain lesions or something like that.

This is actually FUD based on an experimental mishap: https://en.wikipedia.org/wiki/Retracted_article_on_dopaminer...